Pfizer Profit Misses as Breast Cancer Drug Sales Fall Short of Estimates

Reuters  |

(Reuters) - Pfizer Inc posted a quarterly profit on Tuesday that came in below Wall Street estimates, as sales of breast cancer drug Ibrance fell short of expectations.

Under Albert Bourla, who took the helm at the start of last year, Pfizer has streamlined operations and announced plans to separate its off-patent branded drugs business, Upjohn, and combine it with generic drugmaker Mylan NV.

The company said it expects 2020 adjusted earnings per share to be in the range $2.82 to $2.92. Excluding Upjohn unit, it expects full-year adjusted earnings in the range $2.25 to $2.35 per share.

Subscribe to get our Daily Fix delivered to you inbox 5 days a week

Sales of breast cancer drug Ibrance rose 13.2% to $1.28 billion in the fourth quarter, but missed the consensus estimate of $1.35 billion, according to IBES data from Refinitiv.

Revenue fell 9% to $12.69 billion, partly hurt by intense competition for its pain treatment Lyrica that lost patent protection last year.

Excluding items, it earned 55 cents per share, missing the average analyst estimate of 58 cents per share.

Net loss attributable to Pfizer narrowed to $337 million, or 6 cents per share, in the quarter, from $394 million, or 7 cents per share, a year earlier.

Reporting by Saumya Sibi Joseph and Tamara Mathias in Bengaluru; Editing by Arun Koyyur and Saumyadeb Chakrabarty.

_____

Source: Reuters

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer. The author of this article, or a firm that employs the author, is a holder of the following securities mentioned in this article : None

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
GOOG

     
XOM

     
BRK.A

     
FB

     
JNJ

     
WFC

     
T

     
NFLX

     
TSLA

     
V

     
UNH

     
PG

     

Markets